American Funds Global Balanced Fund Class F-1 (GBLEX)
Fund Assets | 26.87B |
Expense Ratio | 0.87% |
Min. Investment | $250 |
Turnover | 91.00% |
Dividend (ttm) | 0.62 |
Dividend Yield | 1.60% |
Dividend Growth | 43.59% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Jun 21, 2024 |
Previous Close | 39.80 |
YTD Return | 10.49% |
1-Year Return | 19.24% |
5-Year Return | 36.77% |
52-Week Low | 32.29 |
52-Week High | 39.80 |
Beta (5Y) | 0.98 |
Holdings | 722 |
Inception Date | Feb 1, 2011 |
About GBLEX
The investment seeks the balanced accomplishment of three objectives: long-term growth of capital, conservation of principal and current income. As a balanced fund with global scope, the fund seeks to invest in equity and debt securities around the world that offer the opportunity for growth and/or provide dividend income, while also constructing the portfolio to protect principal and limit volatility. It will allocate its assets among various countries. The fund will invest at least 40% of its net assets in issuers outside the United States. Normally it will invest at least 25% of the value of its assets in bonds and other debt securities.
Performance
GBLEX had a total return of 19.24% in the past year. Since the fund's inception, the average annual return has been 5.98%, including dividends.
Top 10 Holdings
22.93% of assetsName | Symbol | Weight |
---|---|---|
Capital Group Central Cash Fund | n/a | 6.71% |
Microsoft Corporation | MSFT | 3.24% |
Broadcom Inc. | AVGO | 2.95% |
Meta Platforms, Inc. | META | 1.75% |
Canadian Natural Resources Limited | CNQ | 1.58% |
RTX Corporation | RTX | 1.53% |
Apple Inc. | AAPL | 1.40% |
Sanofi | SAN | 1.30% |
Freeport-McMoRan Inc. | FCX | 1.29% |
Novo Nordisk A/S | NOVO.B | 1.18% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jun 21, 2024 | $0.216 | Jun 24, 2024 |
Mar 22, 2024 | $0.1153 | Mar 25, 2024 |
Dec 19, 2023 | $0.1418 | Dec 20, 2023 |
Sep 22, 2023 | $0.1432 | Sep 25, 2023 |
Jun 23, 2023 | $0.186 | Jun 26, 2023 |
Mar 24, 2023 | $0.0975 | Mar 27, 2023 |